recent headlines // Archives // To submit COVID-19 related news items, email scoop@uth.tmc.edu
An anti-inflammatory compound may have the potential to treat systemic inflammation and brain injury in patients with severe COVID-19 and significantly reduce their chances of death, according to a new study from McGovern Medical School and other institutions. A team...
The McGovern Center for Humanities and Ethics and the Office of Student Affairs and Admissions presents a COVID Memorial Recital with musical performances from the McGovern community, Feb. 10. The recital was organized by Timothy George, MS4, and will honor...
The McGovern Medical School Departments of Anesthesiology and Emergency Medicine are studying the long-term impact of COVID-19 and the potential effect of the hypoxia inducible factor (HIF) medication Vadadustat on organ injury and overall recovery. While most patients recover from...
COVID-19 convalescent plasma showed a likely benefit for patients early in the pandemic before remdesivir and corticosteroids were in use, according to results of a landmark study published in JAMA Internal Medicine that included physician-scientists at UTHealth Houston. UTHealth Houston...
A $3.7 million grant to identify patients at risk for developing chronic consequences of COVID-19 infection and discover potential underlying mechanisms leading to neuropsychiatric symptoms (NPS) has been awarded to Louise McCullough, MD, PhD, and Fudong Liu, MD, MSN, by...
McGovern Medicine Online Publication // Read More
Seen Across Campus // Archives
Our Experts in the News // Media inquiries need to be directed to the
Media Relations Hotline: 713-500-3030.
Some people get COVID, flu and RSV at the same time, and coinfections are worst for young kids
January 19, 2023
Source: MSN
New fast-spreading COVID variant XBB.1.5 arrives in Houston as experts warn of waning immunity
January 4, 2023
Source: Houston Chronicle
Houstonians Face Tripledemic as Cases of Illness Continue to Soar
December 20, 2022
Source: Houston Press
